Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes

Diabetic retinopathy is a prominent cause of blindness in adults, with early retinal ganglion cell loss contributing to visual dysfunction or blindness. In the brain, defects in γ-aminobutyric acid synaptic transmission are associated with pathophysiological and neurodegenerative disorders, whereas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu-Qi Shao, Yong-Chen Wang, Lu Wang, Hang-Ze Ruan, Yun-Feng Liu, Ti-Hui Zhang, Shi-Jun Weng, Xiong-Li Yang, Yong-Mei Zhong
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-02-01
Series:	Neural Regeneration Research
Subjects:	diabetic retinopathy glucagon-like peptide-1 inhibitory synaptic transmission miniature inhibitory postsynaptic currents neurodegeneration neuroprotection patch-clamp recording protein kinase c signaling pathway visual function
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00001
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes

Similar Items